Compounds > ciprofloxacin

ciprofloxacin and oritavancin

ciprofloxacin has been researched along with oritavancin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (87.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arhin, FF; Belley, A; Draghi, DC; Grover, P; McKay, GA; Moeck, G; Parr, TR; Sahm, DF; Sarmiento, I1
Arhin, FF; Bassett, A; Bassett, J; Heine, HS; Ivins, BE; Lehoux, D; Miller, L; Moeck, G; Parr, TR1
Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF1
Esposito, S; Ianniello, F; Noviello, S1
Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM1
Seral, C; Tulkens, PM; Van Bambeke, F1
Arhin, FF; Huggler, E; Lew, DP; Moeck, G; Renzoni, A; Vaudaux, P1
Blaskovich, MAT; Cooper, MA; Gong, Y; Kavanagh, A; Ramu, S1

Other Studies

8 other study(ies) available for ciprofloxacin and oritavancin

ArticleYear
Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Adsorption; Animals; Anti-Bacterial Agents; Bacterial Infections; Carbon Radioisotopes; Culture Media, Conditioned; Enterococcus; Glycopeptides; Horses; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Polysorbates; Radioligand Assay; Staphylococcus; Streptococcus; Surface Properties; Teicoplanin

2008
Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Administration, Inhalation; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Disease Models, Animal; Glycopeptides; Humans; Lipoglycopeptides; Mice; Microbial Sensitivity Tests; Spores, Bacterial; Treatment Outcome

2008
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:11

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus

2009
In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Synergism; Enterococcus; Glycopeptides; Gram-Positive Cocci; Humans; Lipoglycopeptides

2001
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
    Chemotherapy, 2001, Volume: 47, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Incidence; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Spain; Streptomycin; Vancomycin

2001
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Lymphoma, Large B-Cell, Diffuse; Macrophages; Mice; Microbial Sensitivity Tests; Microscopy, Electron; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Tumor Cells, Cultured

2003
Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Erythromycin; Glycopeptides; Hospitals, Teaching; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Switzerland; Vancomycin

2009
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Calcium; Ciprofloxacin; Colistin; Culture Media; Depsipeptides; Escherichia coli; Factor Analysis, Statistical; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Plastics; Polymyxin B; Polysorbates; Rifampin; Teicoplanin; Trimethoprim; Vancomycin

2019